Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Endoskopie in Österreich (Stand 2010)
Kardiologie in Österreich (Stand 2006)
Osteologie in Österreich (Stand 2016)
Fachbücher
Patientenliteratur
Malendowicz SL, Chen T, Ennezat PF, Evans T, Jorde UP, LeJemtel TH, Murray L, Sonnenblick EH The 1166A/C polymorphism of the angiotensin II type 1 receptor gene does not correlate with the blood pressure response to angiotensin II in patients with CHF Journal of Clinical and Basic Cardiology 2001; 4 (1): 75-77 PDF Summary Overview
| ||||||
Figure/Graphic 2: Angiotensin II - Dosierung Effective dose of Angiotensin II (AII) (ng/kg) (Pd 20) required to produce increase in Radial Artery Systolic Pressure (RASP) by 20 mmg/Hg was similar in patients with AA and AC/CC polymorphism of AT1 receptor gene. Graph represents the AII Pd 20 in patients with AA and AC/CC polymorphism of AT1 receptor gene 11.35 +/- 1.18 vs 13.21 +/- 2.2 respectively (p = 0.42). |
Figure/Graphic 2: Angiotensin II - Dosierung
Effective dose of Angiotensin II (AII) (ng/kg) (Pd 20) required to produce increase in Radial Artery Systolic Pressure (RASP) by 20 mmg/Hg was similar in patients with AA and AC/CC polymorphism of AT1 receptor gene. Graph represents the AII Pd 20 in patients with AA and AC/CC polymorphism of AT1 receptor gene 11.35 +/- 1.18 vs 13.21 +/- 2.2 respectively (p = 0.42). |